A heating and freezing process known as dual thermal ablation can kill pancreatic cancer cells, according to new research from Binghamton University, State University at New York.
The collaborative study, conducted by researchers from academia and industry and funded by grants from the National Cancer Institute, used pancreatic cancer cells to investigate the effect of heating and freezing on cell death. The research was conducted by Robert Van Buskirk and John Baust, professors of biological sciences and directors at Binghamton University’s Institute of Biomedical Technology, and Kenneth Baumann, a graduate student studying biology.
“How do we solve the problem of pancreatic cancer when it comes to trying to get rid of the tumor, when chemo and radiation just simply doesn’t work?” said Van Buskirk. “The whole idea is, can one come up with a different surgical intervention that’s less invasive and more effective?
“In order to figure that out, you can commercially obtain pancreatic cancer cells and grow them on specialized plasticware,” Van Buskirk said. “The basic question is, are both freezing and heat in combination more effective than freezing or heat alone? If you freeze pancreatic cancer cells like you do in cryoablation, a lot of them die, but some will survive and regrow. If you heat them, they’ll die, but again some will come back. But with dual-thermal ablation, for reasons that we do not yet understand, more die and don’t come back. In fact, over time, cells that survive the initial insult continue to die.”
“What we’ve observed is that we are able to achieve complete cell death using a combination of heating and then freezing at temperatures that alone would not be lethal to kill pancreatic cancer cells,” said Baumann.
Researchers heated and froze cancer cells and looked at the effect, using various technologies to determine the level of cell death, on regrowth as well as which cell stress pathways were activated.
“Using a variety of assays, we are able to determine the initial level of cell death as well as to what extent the surviving population is able to regrow,” Baumann said. “We were also able to determine the specific paths of cell death activated as a result of the dual thermal exposure.”
“When cells are disturbed—which means they are frozen or they see heat—various cell stress pathways are activated,” said Van Buskirk. “The interesting thing about cells, especially cancer cells, is that they will activate pathways to protect themselves. The objective of this line of molecular-based research is to find out which stress pathways are activated in pancreatic cancer cells so that we can better understand why dual-thermal ablation appears to be more effective.”
“Current studies are focused on elucidating which stress pathways specifically cause these cells to die or what is keeping them alive. That way, we can optimize this treatment to be as effective as possible against pancreatic cancer,” Baumann said.
According to Van Buskirk, modulating these stress pathways is the key to making the heating and freezing ablation process more effective. This could lead to the development of a new way to remove cancerous pancreatic tumors.
In addition to the cell molecular research, several members of the study team are working on developing new catheter technologies to deliver this ablative therapy to patients. “If a very thin catheter can be developed to target the tumor, and if we understand how pancreatic cancer responds to ablation at the molecular level, then we may be able to develop a new therapy to approach something that has been completely unapproachable, the targeted killing of a tumor in a very difficult place: the pancreas,” said Van Buskirk.
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- UK health service to pilot blood test that may detect 50 types of canceron November 27, 2020 at 11:26 am
The UK's National Health Service (NHS) is to pilot a simple blood test that may detect more than 50 types of cancer and, it is hoped, could help thousands of people by allowing the disease to be ...
- Blood Test That Detects 50 Types of Cancer To Be Testedon November 27, 2020 at 5:32 am
Researchers hope the Galleri blood test will be a "gamechanger" for early cancer diagnosis, potentially saving many lives.
- Pancreatic Cancer Therapeutics Diagnostics Market Growth Rate and Development Analysis to 2022on November 26, 2020 at 8:09 am
The uncontrolled growth of cells in the pancreas causes pancreatic cancer. It is an abnormal, unrestrained growth of ...
- Pancreatic cancer month - join the fight | Houghtaling and Downeyon November 24, 2020 at 3:46 am
By supporting research, staying vigilant about our own health and risk factors, and making our families and friends aware of this deadly disease, we will help drive the search for hope and a cure." ...
- U.S. pancreatic cancer deaths are expected to total 47,500 in 2020on November 23, 2020 at 6:08 pm
In 2020, deaths from pancreatic cancer in the United States are expected to total 47,500, according to the National Cancer Institute.
- November marks Pancreatic Cancer Awareness Monthon November 23, 2020 at 11:07 am
November is Pancreatic Cancer Awareness Month. Pancreatic cancer is extremely hard to detect and is the third leading cause of cancer-related deaths in the United States. Julie Fleshman, the president ...
- Pancreatic Cancer Market Research Based on COVID 19 and Analysis on Techniques and Applications Report 2020-2027on November 23, 2020 at 1:40 am
The Global Pancreatic Cancer Market is expected to exceed more than US$ 13 billion by 2024. Browse Full Report: Pancreatic cancer is origins by the unrestrained boom of cells within the pancreas.
- Alex Trebek raises awareness of ‘terrible’ pancreatic cancer in pre-recorded ‘Jeopardy!’ videoon November 20, 2020 at 3:39 pm
During the beginning of Thursday’s episode of “Jeopardy!”, the late veteran TV personality shared a pre-taped message on the day dedicated to raising awareness and funds for pancreatic cancer.
- Alex Trebek spreads awareness about 'terrible' pancreatic cancer on pre-recorded 'Jeopardy!'on November 20, 2020 at 8:33 am
In honor of World Pancreatic Cancer Day, "Jeopardy!" aired a pre-recorded show featuring Alex Trebek's touching message about pancreatic cancer.
- The University of Verona and IntraOp® Announce PancFORT Trial for Pancreatic Canceron November 20, 2020 at 3:41 am
IntraOp Medical Corporation and the University of Verona in Italy announced today the enrollment of the first patient in the PancFORT Trial: A phase II study of primary chemotherapy, stereotactic body ...
via Bing News